Genetic Signatures (ASX:GSS)
ASX announcement history & article coverage
Transparent by design.
Announcments by Genetic Signatures (ASX:GSS) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Becoming a substantial holder from BDX
GSS responds to the BCAL Diagnostics Announcement
Genetic Signatures responds to BCAL share acquisition announcement, confirms no prior knowledge
Ceasing to be a substantial holder
Change of Company Secretary
Change in substantial holding
Change in substantial holding
Investor Presentation
Investor Webinar Notification
Final Director's Interest Notice
Board Reorganisation
Change in substantial holding
Quarterly Activities/Appendix 4C Cash Flow Report
Genetic Signatures reports $3M Q3 sales, $25.7M cash, $5M annual cost savings from restructure, and signs 10-year Danish supply deal
Change in substantial holding
Change in substantial holding
Change in substantial holding
Danish Supply Agreement - Additional Information
Genetic Signatures' Danish Supply Agreement to Add 6% to Annual Sales from September 2026
Pause in Trading
Genetic Signatures Limited trading halt announced
Genetic Signatures Signs Danish Supply Agreement
Genetic Signatures Secures 10-Year Danish Supply Agreement for Pan-Enteric Diagnostic Assay
